MZL
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL (NCT05176691) | Hutchmed | 2022-02-15 |
| A Study to Evaluate ICP-022 in Patients With R/R Marginal Zone Lymphoma (MZL) (NCT03797456) | Beijing InnoCare Pharma Tech Co., Ltd. | 2019-04-01 |
| Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma (NCT03846427) | BeiGene | 2019-02-19 |
Track MZL automatically
Every clearance here is in the API, with alerts when new ones post.